Cyfuse Biomedical K.K. is a pioneering company based in Tokyo, specializing in advanced bioprinting technologies for regenerative medicine. The organization focuses on developing innovative solutions for tissue engineering, utilizing its proprietary 3D bioprinting platform to create complex tissue structures. By integrating cutting-edge research in biomaterials and cellular biology, Cyfuse aims to address critical challenges in medical treatments and enhance therapeutic outcomes in various applications, including organ transplantation and drug testing.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

10 Patents

#1,914 in Tokyo

#4,401 in Japan

#56,047 in the World

Tokyo, Japan

Cyfuse Biomedical K.k.

Forward Citations = 4

29 inventors:

Toshihiko Maekawa (3 out of 3 patents)

Yasuto Kishii (2 out of 4 patents)

Koichi Nakayama (2 out of 6 patents)

4. Ryo Hasebe (2 out of 8 patents)

5. Kumika Matsubayashi (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cyfuse Biomedical K.k.. Retrieved from https://idiyas.com/company/cyfuse-biomedical-k-k

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

7 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]